rs7241307

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001378183.1(PIEZO2):​c.1201-19C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0634 in 1,495,352 control chromosomes in the GnomAD database, including 3,319 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.056 ( 293 hom., cov: 33)
Exomes 𝑓: 0.064 ( 3026 hom. )

Consequence

PIEZO2
NM_001378183.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 3.31

Publications

5 publications found
Variant links:
Genes affected
PIEZO2 (HGNC:26270): (piezo type mechanosensitive ion channel component 2) The protein encoded by this gene contains more than thirty transmembrane domains and likely functions as part of mechanically-activated (MA) cation channels. These channels serve to connect mechanical forces to biological signals. The encoded protein quickly adapts MA currents in somatosensory neurons. Defects in this gene are a cause of type 5 distal arthrogryposis. Several alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]
PIEZO2 Gene-Disease associations (from GenCC):
  • Gordon syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • arthrogryposis, distal, with impaired proprioception and touch
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics
  • arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • connective tissue disorder
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • Marden-Walker syndrome
    Inheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 18-10801447-G-C is Benign according to our data. Variant chr18-10801447-G-C is described in ClinVar as Benign. ClinVar VariationId is 261496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0646 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIEZO2NM_001378183.1 linkc.1201-19C>G intron_variant Intron 9 of 55 ENST00000674853.1 NP_001365112.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIEZO2ENST00000674853.1 linkc.1201-19C>G intron_variant Intron 9 of 55 NM_001378183.1 ENSP00000501957.1 A0A2H4UKA7

Frequencies

GnomAD3 genomes
AF:
0.0562
AC:
8556
AN:
152160
Hom.:
293
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0462
Gnomad AMI
AF:
0.00987
Gnomad AMR
AF:
0.0434
Gnomad ASJ
AF:
0.0525
Gnomad EAS
AF:
0.00442
Gnomad SAS
AF:
0.0408
Gnomad FIN
AF:
0.0878
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0662
Gnomad OTH
AF:
0.0598
GnomAD2 exomes
AF:
0.0519
AC:
7578
AN:
146006
AF XY:
0.0521
show subpopulations
Gnomad AFR exome
AF:
0.0494
Gnomad AMR exome
AF:
0.0401
Gnomad ASJ exome
AF:
0.0484
Gnomad EAS exome
AF:
0.00216
Gnomad FIN exome
AF:
0.0868
Gnomad NFE exome
AF:
0.0647
Gnomad OTH exome
AF:
0.0582
GnomAD4 exome
AF:
0.0643
AC:
86305
AN:
1343074
Hom.:
3026
Cov.:
30
AF XY:
0.0637
AC XY:
42335
AN XY:
664686
show subpopulations
African (AFR)
AF:
0.0450
AC:
1375
AN:
30588
American (AMR)
AF:
0.0434
AC:
1547
AN:
35622
Ashkenazi Jewish (ASJ)
AF:
0.0507
AC:
1266
AN:
24958
East Asian (EAS)
AF:
0.00113
AC:
40
AN:
35516
South Asian (SAS)
AF:
0.0432
AC:
3385
AN:
78322
European-Finnish (FIN)
AF:
0.0846
AC:
2978
AN:
35210
Middle Eastern (MID)
AF:
0.0286
AC:
161
AN:
5634
European-Non Finnish (NFE)
AF:
0.0694
AC:
72230
AN:
1040482
Other (OTH)
AF:
0.0586
AC:
3323
AN:
56742
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
3625
7251
10876
14502
18127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2712
5424
8136
10848
13560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0562
AC:
8560
AN:
152278
Hom.:
293
Cov.:
33
AF XY:
0.0566
AC XY:
4213
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.0462
AC:
1918
AN:
41558
American (AMR)
AF:
0.0434
AC:
663
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0525
AC:
182
AN:
3468
East Asian (EAS)
AF:
0.00444
AC:
23
AN:
5186
South Asian (SAS)
AF:
0.0404
AC:
195
AN:
4826
European-Finnish (FIN)
AF:
0.0878
AC:
932
AN:
10610
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0662
AC:
4506
AN:
68016
Other (OTH)
AF:
0.0596
AC:
126
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
423
846
1269
1692
2115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0577
Hom.:
47
Bravo
AF:
0.0532
Asia WGS
AF:
0.0230
AC:
81
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
15
DANN
Benign
0.41
PhyloP100
3.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7241307; hg19: chr18-10801445; API